Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Growth Hormone & Performance · Philadelphia, PA
HGH Fragment 176-191 is documented by ReVia for research groups throughout Philadelphia and the surrounding East Coast research belt, from Cherry Hill to Wilmington. This C-terminal fragment of human growth hormone is investigated for lipolysis and fat metabolism pathways in laboratory models, supplied exclusively for research use. Each batch arrives with third-party COA verification, giving investigators in the region documented purity and identity for reproducible benchwork.
The C-terminal fragment of human growth hormone (amino acids 176-191) studied for its lipolytic properties. Research has investigated its ability to modulate fat metabolism without the growth-promoting or diabetogenic effects of full-length hGH.
HGH Fragment 176-191 is investigated within growth-hormone fragment research, focused on lipolytic signaling and fat-metabolism enzymology in vitro. Along the Northeast pharma and research corridor, bench teams in Philadelphia, King of Prussia, Cherry Hill, and Wilmington reference the peptide when framing structure-function studies, keeping every adipocyte and metabolic assay within strictly preclinical, research-use-only limits.
HGH Fragment 176-191 is worked with by researchers throughout the Philadelphia metro — including King of Prussia, Cherry Hill, Wilmington, Camden — and across East Coast. The Northeast's pharma and research corridor. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Philadelphia lab obtain HGH Fragment 176-191?
These compounds are supplied through i2b Health, ReVia's research partner, to researchers in Philadelphia and adjacent King of Prussia, Cherry Hill, and Wilmington. All packages are designated research-use-only.
Does HGH Fragment 176-191 come with third-party testing?
Each lot includes an independent third-party Certificate of Analysis. The COA confirms purity and compound identity before research begins.
What is HGH Fragment 176-191 researched for?
It is studied in preclinical settings for lipolysis and fat metabolism pathways without affecting insulin sensitivity markers. It is intended for laboratory research only and is not a treatment.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.